2028

500259

LYKALABS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

LYKA LABS LTD Share Price Today

LYKA LABS LTD is currently trading at ₹69.6, up by ₹0.59 from the previous close. The stock touched an intraday high of ₹71.49 and a low of ₹68.30 during the latest trading session. Over the past one year, LYKA LABS LTD has delivered a loss of 41.38%, while the stock has gained 13.68% in the last one month.

LYKA LABS LTD performance

Today’s low Today’s high
₹ 68.30 ₹ 71.49
₹ 69.60
52 week low 52 week high
₹ 44.10 ₹ 125.50
₹ 69.60
Open Price ₹ 68.30
Prev. Close ₹ 69.00
Volume (Shares) 30718.00
Total traded value ₹ 21.37
Upper Circuit ₹ 75.90
Lower Circuit ₹ 62.10
info

Investment Returns

Over 1 Month 13.68% Over 3 Months 26.70% Over 6 Months -10.41% Over 1 Year -41.38%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

LYKA LABS LTD fundamentals


  • Market cap (Cr) 248.40
  • P/E Ratio (TTM) -7.66
  • Beta 1.11
  • Book Value / share 24.37
  • Return on equity 4.99%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) -29.77
info icon alternate text
  • Market cap (Cr) 247.40
  • P/E Ratio (TTM) -7.66
  • Beta 0.98
  • Book Value / share 24.37
  • Return on equity 4.99%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) -29.77
info icon alternate text

LYKA LABS LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 28.03
Operating Expense 35.43
Net Profit -29.77
Net Profit Margin (%) -106.20
Earnings Per Share (EPS) -8.34
EBITDA -26.99
Effective Tax Rate (%) 0.43
Particulars DEC 2025 (Values in Cr)
Revenue 30.73
Operating Expense 31.81
Net Profit 0.29
Net Profit Margin (%) 0.94
Earnings Per Share (EPS) 0.08
EBITDA 3.26
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 32.97
Operating Expense 38.99
Net Profit -3.63
Net Profit Margin (%) -11.01
Earnings Per Share (EPS) -1.02
EBITDA -1.94
Effective Tax Rate (%) 24.37
Particulars JUN 2025 (Values in Cr)
Revenue 29.18
Operating Expense 28.67
Net Profit 0.81
Net Profit Margin (%) 2.77
Earnings Per Share (EPS) 0.22
EBITDA 4.05
Effective Tax Rate (%) 30.76
Particulars MAR 2025 (Values in Cr)
Revenue 30.52
Operating Expense 29.16
Net Profit 1.23
Net Profit Margin (%) 4.03
Earnings Per Share (EPS) 0.36
EBITDA 4.12
Effective Tax Rate (%) 43.57
Particulars MAR 2026 (Values in Cr)
Revenue 120.91
Operating Expense 135.10
Net Profit -32.29
Net Profit Margin (%) -26.70
Earnings Per Share (EPS) -9.05
EBITDA -21.45
Effective Tax Rate (%) 2.85
Particulars MAR 2025 (Values in Cr)
Revenue 134.70
Operating Expense 126.35
Net Profit 7.92
Net Profit Margin (%) 5.87
Earnings Per Share (EPS) 2.28
EBITDA 20.16
Effective Tax Rate (%) 28.64
Particulars MAR 2024 (Values in Cr)
Revenue 106.40
Operating Expense 108.92
Net Profit -2.27
Net Profit Margin (%) -2.13
Earnings Per Share (EPS) -0.72
EBITDA 16.16
Effective Tax Rate (%) -144.08
Particulars MAR 2023 (Values in Cr)
Revenue 80.59
Operating Expense 90.08
Net Profit -13.29
Net Profit Margin (%) -16.49
Earnings Per Share (EPS) -4.65
EBITDA 11.87
Effective Tax Rate (%) -0.60
Particulars MAR 2022 (Values in Cr)
Revenue 164.35
Operating Expense 102.16
Net Profit 39.90
Net Profit Margin (%) 24.27
Earnings Per Share (EPS) 13.87
EBITDA 95.55
Effective Tax Rate (%) 33.76
Particulars MAR 2025 (Values in Cr)
Book Value / Share 29.01
ROE % 5.25
ROCE % 6.62
Total Debt to Total Equity 0.55
EBITDA Margin 14.56
Particulars MAR 2024 (Values in Cr)
Book Value / Share 17.86
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.14
EBITDA Margin 15.44
Particulars MAR 2023 (Values in Cr)
Book Value / Share 9.12
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 3.36
EBITDA Margin 21.75
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4.65
ROE % 77.59
ROCE % 40.57
Total Debt to Total Equity 0.00
EBITDA Margin 53.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share -8.99
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 23.33
Particulars MAR 2025 (Values in Cr)
Book Value / Share 37.81
ROE % 4.99
ROCE % 6.37
Total Debt to Total Equity 0.41
EBITDA Margin 15.02
Particulars MAR 2024 (Values in Cr)
Book Value / Share 27.28
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.73
EBITDA Margin 15.18
Particulars MAR 2023 (Values in Cr)
Book Value / Share 19.22
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.64
EBITDA Margin 23.64
Particulars MAR 2022 (Values in Cr)
Book Value / Share 15.49
ROE % 58.27
ROCE % 35.98
Total Debt to Total Equity 5.77
EBITDA Margin 58.14
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1.54
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 12.15
EBITDA Margin 24.41
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.34
Total Assets 176.20
Total Liabilities 176.20
Total Equity 103.58
Share Outstanding 3
Price to Book Ratio 2.67
Return on Assets (%) 4.54
Return on Capital (%) 5.66
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.94
Total Assets 156.85
Total Liabilities 156.85
Total Equity 68.26
Share Outstanding 3
Price to Book Ratio 3.88
Return on Assets (%) -1.58
Return on Capital (%) -1.99
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.71
Total Assets 151.52
Total Liabilities 151.52
Total Equity 45.67
Share Outstanding 3
Price to Book Ratio 5.45
Return on Assets (%) -8.71
Return on Capital (%) -11.26
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 17.05
Total Assets 185.61
Total Liabilities 185.61
Total Equity 13.49
Share Outstanding 2
Price to Book Ratio 8.75
Return on Assets (%) 21.01
Return on Capital (%) 27.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 7.15
Total Assets 190.01
Total Liabilities 190.01
Total Equity -25.09
Share Outstanding 2
Price to Book Ratio 16.88
Return on Assets (%) -6.08
Return on Capital (%) -8.45
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.31
Total Assets 205.57
Total Liabilities 205.57
Total Equity 134.94
Share Outstanding 3
Price to Book Ratio 2.67
Return on Assets (%) 4.00
Return on Capital (%) 4.76
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.88
Total Assets 186.01
Total Liabilities 186.01
Total Equity 99.32
Share Outstanding 3
Price to Book Ratio 3.88
Return on Assets (%) -1.21
Return on Capital (%) -1.46
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.69
Total Assets 178.85
Total Liabilities 178.85
Total Equity 76.42
Share Outstanding 3
Price to Book Ratio 5.45
Return on Assets (%) -7.42
Return on Capital (%) -9.01
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 15.38
Total Assets 208.51
Total Liabilities 208.51
Total Equity 44.43
Share Outstanding 2
Price to Book Ratio 8.75
Return on Assets (%) 19.13
Return on Capital (%) 23.11
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.52
Total Assets 213.37
Total Liabilities 213.37
Total Equity 4.40
Share Outstanding 2
Price to Book Ratio 16.88
Return on Assets (%) -6.77
Return on Capital (%) -8.73
Particulars MAR 2025 (Values in Cr)
Net Income 11.12
Cash from Operations 4.93
Cash from Investing -11.79
Cash from Financing 5.29
Net change in Cash -4.60
Free Cash Flow 20.58
Particulars MAR 2024 (Values in Cr)
Net Income -0.93
Cash from Operations 3.29
Cash from Investing -9.48
Cash from Financing 1.95
Net change in Cash -5.76
Free Cash Flow 12.52
Particulars MAR 2023 (Values in Cr)
Net Income -13.17
Cash from Operations 8.74
Cash from Investing 7.35
Cash from Financing -21.64
Net change in Cash -5.33
Free Cash Flow 16.93
Particulars MAR 2022 (Values in Cr)
Net Income 59.24
Cash from Operations 80.16
Cash from Investing -6.17
Cash from Financing -63.17
Net change in Cash 9.89
Free Cash Flow 87.67
Particulars MAR 2021 (Values in Cr)
Net Income -14.14
Cash from Operations 9.61
Cash from Investing -0.16
Cash from Financing -11.79
Net change in Cash -3.14
Free Cash Flow 10.88
Particulars MAR 2025 (Values in Cr)
Net Income 11.47
Cash from Operations 6.24
Cash from Investing -13.09
Cash from Financing 5.26
Net change in Cash -4.56
Free Cash Flow 21.94
Particulars MAR 2024 (Values in Cr)
Net Income -0.93
Cash from Operations 4.55
Cash from Investing -8.60
Cash from Financing 2.70
Net change in Cash -2.80
Free Cash Flow 13.79
Particulars MAR 2023 (Values in Cr)
Net Income -13.20
Cash from Operations 7.28
Cash from Investing 6.76
Cash from Financing -20.32
Net change in Cash -6.68
Free Cash Flow 16.11
Particulars MAR 2022 (Values in Cr)
Net Income 60.24
Cash from Operations 77.08
Cash from Investing -4.32
Cash from Financing -63.35
Net change in Cash 8.85
Free Cash Flow 83.00
Particulars MAR 2021 (Values in Cr)
Net Income -18.39
Cash from Operations 6.47
Cash from Investing 0.12
Cash from Financing -7.75
Net change in Cash -1.87
Free Cash Flow 7.73
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 13.39 1.56 248.29 23.12 38.85
BLISS GVS PHARMA LTD 438.10 35.56 3.89 4646.32 118.35 462.70
CIPLA LTD 1388.80 29.47 3.25 112193.56 1165.55 1672.20
FERMENTA BIOTECH LIMITED 338.80 14.94 2.45 997.12 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 22.66 4.17 248.29 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 557.75 25.00 4.35 1612.49 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8243.90 107.66 23.61 20609.75 7630.00 10653.05
BLISS GVS PHARMA LTD 438.10 47.26 4.02 4646.32 118.35 462.70

LYKA LABS LTD shareholding pattern

Holding
40.88%
58.16%
0.28%
0.66%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

LYKA LABS LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
69.60 0.86 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 68.20
  • 26 Days 62.70
  • 10 Days 65.80
  • 50 Days 61.80
  • 12 Days 65.20
  • 100 Days 64.80
  • 20 Days 63.50
  • 200 Days 75.40
70.85 PIVOT
First Support 66.40 First Resistance 73.45 Second Support 63.80 Second Resistance 77.90 Third Support 59.35 Third Resistance 80.50
RSI 65.62 ADX 25.79 MACD 2.42 Williams % R -33.26 Commodity Channel Index (CCI) 141.73
Date 2026-06-12 Week 113136.00 Same Day 20135.00 Month 55061.00
1 Year 1.11 3 Year 1.00
Over 1 Month
13.68% down
Over 1 Year
-41.38% down
Over 3 Months
26.70% down
Over 3 Years
-12.55% down
Over 6 Months
-10.41% down
Over 5 Years
2.94% down

LYKA LABS LTD Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Lyka Labs Ltd?

Answer Field

Lyka Labs Ltd share price is for NSE ₹ 69.60 & for BSE ₹ 69.50 as on Jun 12 2026 03:30 PM.

What is the Market Cap of Lyka Labs Ltd Share?

Answer Field

The market cap of Lyka Labs Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 12 2026 03:30 PM.

What is the 52 Week High and Low of Lyka Labs Ltd?

Answer Field

The 52 Week High and Low of Lyka Labs Ltd for NSE is ₹ 125.50 and ₹ 44.10 and for BSE is ₹ 125.00 and ₹ 44.49.

What is 1 year return for Lyka Labs Ltd?

Answer Field

The 1 year returns on the stock has been -41.38%.

What is the P/E Ratio of Lyka Labs Ltd Share?

Answer Field

As on Jun 12 2026 03:30 PM the price-to-earnings (PE) ratio for Lyka Labs Ltd share is -7.66.

What is the PB ratio of Lyka Labs Ltd Share?

Answer Field

As on Jun 12 2026 03:30 PM, the price-to-book (PB) ratio for Lyka Labs Ltd share is 24.37.

How to Buy Lyka Labs Ltd Share?

Answer Field

You can trade in Lyka Labs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Lyka Labs Ltd Share on Bajaj Broking App?

Answer Field

To buy Lyka Labs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Lyka Labs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|